YaoGeJu

Company directoryChina company filings

Hunan Dongting Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name Hunan Dongting Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 25 active records with this name as holder; 19 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

36 acceptance records as first applicant, grouped into 27 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Clonazepam Tablets 2 records · Latest accepted 2026/04/28

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2650104Supplement2026/04/28Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
CYHB2650103Supplement2026/04/28Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Estazolam Tablets 2 records · Latest accepted 2026/02/25

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2650061Supplement2026/02/25Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
CYHB2650060Supplement2026/02/25Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Escitalopram Oxalate Tablets 1 records · Latest accepted 2025/08/08

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501570Supplement2025/08/08Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Sodium Valproate Sustained-release Tablets(I) 1 records · Latest accepted 2024/12/04

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402052Supplement2024/12/04Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Agomelatine Tablets 1 records · Latest accepted 2024/12/04

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402045Supplement2024/12/04Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Vortioxetine Hydrobromide Tablets 1 records · Latest accepted 2024/11/30

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402024Supplement2024/11/30Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Risperidone Tablets 2 records · Latest accepted 2024/11/26

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401987Supplement2024/11/26Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
CYHB2401986Supplement2024/11/26Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Levodopa and Benserazide Hydrochloride Tablets 1 records · Latest accepted 2024/11/26

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401988Supplement2024/11/26Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Olanzapine Tablets 2 records · Latest accepted 2024/11/26

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401992Supplement2024/11/26Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
CYHB2401991Supplement2024/11/26Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Venlafaxine Hydrochloride Sustained-Release Capsules 1 records · Latest accepted 2024/09/02

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401374Supplement2024/09/02Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Alprazolam Tablets 1 records · Latest accepted 2024/08/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450456Supplement2024/08/29Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Aripiprazole Tablets 1 records · Latest accepted 2024/07/19

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401074Supplement2024/07/19Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Risperidone Orally Disintegrating Tablets 2 records · Latest accepted 2024/07/18

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401063Supplement2024/07/18Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
CYHB2401062Supplement2024/07/18Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Clomipramine Hydrochloride Injection 1 records · Latest accepted 2024/07/04

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450356Supplement2024/07/04Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Mirtazapine Tablets 1 records · Latest accepted 2024/04/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401216Generic2024/04/23Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
氨甲苯酸注射液 · No verified English name 1 records · Latest accepted 2024/03/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400439Supplement2024/03/29Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Atropine Sulfate Injection 1 records · Latest accepted 2024/01/24

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450066Supplement2024/01/24Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Lorazepam Tablets 2 records · Latest accepted 2023/10/24

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350788Supplement2023/10/24Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
CYHB2150734Supplement2021/07/13Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Olanzapine Orally Disintegrating Tablets 2 records · Latest accepted 2023/10/21

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302343Supplement2023/10/21Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
CYHB2302342Supplement2023/10/21Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Pregabalin Capsules 2 records · Latest accepted 2023/10/11

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302239Supplement2023/10/11Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
CYHB2302238Supplement2023/10/11Hunan Dongting Pharmaceutical Co., Ltd.; YaoPharma Co., Ltd.CDE ↗
Fluvoxamine Maleate Tablets 1 records · Latest accepted 2023/08/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302137Generic2023/08/16Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Oxazepam Tablets 1 records · Latest accepted 2023/08/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302048Generic2023/08/01Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Levetiracetam extended-release tablets 1 records · Latest accepted 2023/03/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300802Generic2023/03/16Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Tranexamic Acid Tablets 1 records · Latest accepted 2022/12/08

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250746Supplement2022/12/08Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Haloperidol Lactate Injection 1 records · Latest accepted 2022/04/07

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250205Supplement2022/04/07Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Sulpiride Injection 1 records · Latest accepted 2021/09/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150890Supplement2021/09/29Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Tranexamic Acid Injection 2 records · Latest accepted 2021/09/01

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150839Supplement2021/09/01Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
CYHB2150838Supplement2021/09/01Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Clonazepam Tablets CYHB2650104Supplement2026/04/28Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Clonazepam Tablets CYHB2650103Supplement2026/04/28Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Estazolam Tablets CYHB2650061Supplement2026/02/25Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗
Estazolam Tablets CYHB2650060Supplement2026/02/25Hunan Dongting Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

25 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Venlafaxine Hydrochloride Sustained-Release CapsulesHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H202691012026/04/29Generic approved under the new chemical-drug registration classificationCDE ↗
Clomipramine Hydrochloride InjectionHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H109100162025/10/27Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Atropine Sulfate InjectionHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H430207002025/07/28Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Alprazolam TabletsHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H430205782025/05/21Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Olanzapine TabletsHunan Dongting Pharmaceutical Co., Ltd.YaoPharma Co., Ltd.国药准字H202537032025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Risperidone TabletsHunan Dongting Pharmaceutical Co., Ltd.YaoPharma Co., Ltd.国药准字H202537062025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Olanzapine TabletsHunan Dongting Pharmaceutical Co., Ltd.YaoPharma Co., Ltd.国药准字H202537022025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Risperidone TabletsHunan Dongting Pharmaceutical Co., Ltd.YaoPharma Co., Ltd.国药准字H202537072025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Agomelatine TabletsHunan Dongting Pharmaceutical Co., Ltd.YaoPharma Co., Ltd.国药准字H202535532025/03/04Generic approved under the new chemical-drug registration classificationCDE ↗
Oxazepam TabletsHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H202531412025/01/14Generic approved under the new chemical-drug registration classificationCDE ↗
Aripiprazole TabletsHunan Dongting Pharmaceutical Co., Ltd.YaoPharma Co., Ltd.国药准字H202493022024/11/05Generic approved under the new chemical-drug registration classificationCDE ↗
Fluvoxamine Maleate TabletsHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H202449672024/09/26Generic approved under the new chemical-drug registration classificationCDE ↗
Risperidone Orally Disintegrating TabletsHunan Dongting Pharmaceutical Co., Ltd.YaoPharma Co., Ltd.国药准字H202448412024/09/10Generic approved under the new chemical-drug registration classificationCDE ↗
Risperidone Orally Disintegrating TabletsHunan Dongting Pharmaceutical Co., Ltd.YaoPharma Co., Ltd.国药准字H202448422024/09/10Generic approved under the new chemical-drug registration classificationCDE ↗
Lorazepam TabletsHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H200310652024/07/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Levetiracetam extended-release tabletsHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H202443012024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
Tranexamic Acid TabletsHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H430205642023/10/30Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Haloperidol Lactate InjectionHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H430205552022/12/29Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Sulpiride InjectionHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H430205752022/09/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tranexamic Acid InjectionHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H430205652022/07/22Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tranexamic Acid InjectionHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H201037302022/07/22Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Venlafaxine Hydrochloride Sustained-Release CapsulesHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H202230572022/01/30Generic approved under the new chemical-drug registration classificationCDE ↗
Clozapine TabletsHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H430205712021/04/20Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Amitriptyline Hydrochloride TabletsHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H430205612020/07/31Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Memantine Hydrochloride TabletsHunan Dongting Pharmaceutical Co., Ltd.Hunan Dongting Pharmaceutical Co., Ltd.国药准字H202030162020/01/21Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

19 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
硫酸异帕米星 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20260000168I2026/05/12CDE ↗
氨甲环酸 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20250001276I2025/12/16CDE ↗
阿戈美拉汀 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20240000219A2025/07/21CDE ↗
氟哌啶醇 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20240000082A2025/07/18CDE ↗
奥沙西泮 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20230000532A2025/12/19CDE ↗
氢溴酸伏硫西汀 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20230000195A2024/11/07CDE ↗
布瑞哌唑 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20200001055A2026/05/18CDE ↗
氨甲苯酸 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190007844A2025/03/04CDE ↗
富马酸喹硫平 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190007843A2025/03/04CDE ↗
盐酸美金刚 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190006826A—CDE ↗
盐酸阿米替林 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190004017A2025/03/04CDE ↗
盐酸硫利哒嗪 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190004015A—CDE ↗
格隆溴铵 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190004011A—CDE ↗
氨甲环酸 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190002895A2025/03/04CDE ↗
尼群地平 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190002886A—CDE ↗
盐酸氯米帕明 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190002883A—CDE ↗
劳拉西泮 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190002863A2025/03/04CDE ↗
草酸艾司西酞普兰 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20190001441A2024/10/18CDE ↗
盐酸莫西沙星 · No verified English nameHunan Dongting Pharmaceutical Co., Ltd.Y20180001456I2019/01/08CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.